000 03704nam a22005295i 4500
001 978-3-540-68753-5
003 DE-He213
005 20161121230742.0
007 cr nn 008mamaa
008 100301s2007 gw | s |||| 0|eng d
020 _a9783540687535
_9978-3-540-68753-5
024 7 _a10.1007/978-3-540-68753-5
_2doi
050 4 _aRC254-282
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
245 1 0 _aPediatric Lymphomas
_h[electronic resource] /
_cedited by Howard J. Weinstein, Melissa M. Hudson, Michael P. Link.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2007.
300 _aXII, 292 p. 56 illus., 52 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aPediatric Oncology,
_x1613-5318
505 0 _aand Historical Background: Pediatric Hodgkin Lymphoma -- Biology and Pathology of Hodgkin’s Disease -- Treatment of Pediatric Hodgkin Lymphoma -- Treatment of Relapsed/Refractory Hodgkin Lymphoma -- Non-Hodgkin’s Lymphoma -- Biology and Pathology of Pediatric Non-Hodgkin Lymphoma -- B-Cell Lymphoma/Burkitt Lymphoma -- Anaplastic Large-Cell Lymphoma -- Precursor B and Precursor T-Cell Lymphoblastic Lymphoma -- Cutaneous T-Cell Lymphomas and Rare T-Cell Non-Hodgkin Lymphomas -- Lymphoproliferative Disorders Related to Immunodeficiencies -- Late Effects Following Lymphoma Treatment.
520 _aT is is the f rst edition of Pediatric Lymphomas. T e ment of both Hodgkin and non-Hodgkin lymphomas, editors have been colleagues for more than 25 years and lymphoproliferative disorders associated with - and have been involved in the design and coordination munodef ciency. In addition, three chapters focus on of clinical trials and multimodality approaches for the pathology, molecular biology, and genetics of children with Hodgkin and non-Hodgkin lymphomas. Hodgkin and non-Hodgkin lymphoma including the Progress in elucidating the pathogenesis and in the di- rare cutaneous lymphomas. We hope that Pediatric agnosis and treatment of lymphomas in children has Lymphomas will be a useful resource for practitioners been one of the great success stories in pediatric oncol- from the many dif erent disciplines involved in the ogy. Prior to 1970, fewer than 20% of children with comprehensive care of children with lymphomas. malignant lymphomas survived. Today, more than T e authors are all leading experts in the area of 90% of children diagnosed with Hodgkin lymphoma childhood lymphomas. We wish to thank them for all survive and more than 80% of children with non- of the time and ef ort that went into their contribu- Hodgkin lymphoma are considered cured. Continued tions. If this f rst edition is helpful to our diverse re- improvement in survival has occurred as the result of ership, it is because of the authors.
650 0 _aMedicine.
650 0 _aHematology.
650 0 _aOncology.
650 0 _aPediatrics.
650 0 _aPediatric surgery.
650 1 4 _aMedicine & Public Health.
650 2 4 _aOncology.
650 2 4 _aHematology.
650 2 4 _aPediatrics.
650 2 4 _aPediatric Surgery.
700 1 _aWeinstein, Howard J.
_eeditor.
700 1 _aHudson, Melissa M.
_eeditor.
700 1 _aLink, Michael P.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783540203568
830 0 _aPediatric Oncology,
_x1613-5318
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-540-68753-5
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c503463
_d503463